Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Opinion in HIV and AIDS
|
January 10, 2012
Treatment-for-prevention: clinical considerations
Shahin Lockman, Paul Sax
AIDS Patient Care and Stds
|
June 21, 2003
Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications
Charles Hicks, Judith Currier, Paul Sax, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2019
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety Analysis
Melanie Thompson, Chloe Orkin, Jean-Michel Molina, et al.
Cell Reports
|
December 21, 2017
Transcriptional Changes during Naturally Acquired Zika Virus Infection Render Dendritic Cells Highly Conducive to Viral Replication
Xiaoming Sun, Stephane Hua, Hsiao-Rong Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine
Kimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Antiviral Therapy
|
August 30, 2013
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study
David A Wohl, Gretchen Arnoczy, Carl J Fichtenbaum, et al.
Infection & Chemotherapy
|
October 6, 2016
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials
Jun Yong Choi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2026
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV
Risa Hoffman, Sean Brummel, Mauricio Pinilla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Opinion in HIV and AIDS
|
January 10, 2012
Treatment-for-prevention: clinical considerations
Shahin Lockman, Paul Sax
AIDS Patient Care and Stds
|
June 21, 2003
Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications
Charles Hicks, Judith Currier, Paul Sax, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 24, 2019
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety Analysis
Melanie Thompson, Chloe Orkin, Jean-Michel Molina, et al.
Cell Reports
|
December 21, 2017
Transcriptional Changes during Naturally Acquired Zika Virus Infection Render Dendritic Cells Highly Conducive to Viral Replication
Xiaoming Sun, Stephane Hua, Hsiao-Rong Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine
Kimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Antiviral Therapy
|
August 30, 2013
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study
David A Wohl, Gretchen Arnoczy, Carl J Fichtenbaum, et al.
Infection & Chemotherapy
|
October 6, 2016
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials
Jun Yong Choi, Somnuek Sungkanuparph, Thanomsak Anekthananon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2026
Hypertension in a randomized trial of dolutegravir- versus efavirenz-based antiretroviral therapy in pregnant and postpartum women with HIV
Risa Hoffman, Sean Brummel, Mauricio Pinilla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 5, 2024
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Risa M Hoffman, Sean Brummel, Lauren Ziemba, et al.
Page
of 1